Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FYP18
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,379
Award facts
- Contract value 100% obligated
- $16,379.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order awards $16.4K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Keytruda 100 mg/4 mL vials. The Defense Logistics Agency issued this firm fixed-price delivery order on May 27, 2025, with an ultimate completion date of June 17, 2025. Performance will occur at the contractor's facility in Park Ridge, Illinois. No set-aside designation was used for this award. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at approximately $500M and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in DLA procurement markets. The contractor specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems. Keytruda, an oncology immunotherapy medication, represents one of many specialized pharmaceutical products the company supplies under its master contract, which covers prescription medications, vaccines, injections, and various specialty pharmaceuticals essential to military medical operations globally.
Quick answers
Who was awarded contract SPE2DB25FYP18?
SPE2DB25FYP18 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 27, 2025.
How much is contract SPE2DB25FYP18 worth?
The government has obligated $16,379 on SPE2DB25FYP18.
Is contract SPE2DB25FYP18 an order under another contract?
Yes. SPE2DB25FYP18 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYP18 competed?
The extent of competition for SPE2DB25FYP18 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award